Detalles de la búsqueda
1.
Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification.
Prostate
; 2024 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734990
2.
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.
Cancer
; 130(10): 1766-1772, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280206
3.
Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer.
Histopathology
; 84(4): 614-623, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012532
4.
PSA density does not improve predictive accuracy of the UCSF-CAPRA score.
Prostate
; 83(10): 922-928, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37078628
5.
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Mod Pathol
; 36(10): 100241, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343766
6.
Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging.
J Urol
; 210(2): 281-289, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099018
7.
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort.
J Urol
; 209(1): 198-207, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36067374
8.
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
Eur J Nucl Med Mol Imaging
; 2023 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012448
9.
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study.
BMC Cancer
; 23(1): 1191, 2023 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38053037
10.
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.
Nutr Cancer
; 75(2): 618-626, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36343223
11.
Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record?
J Sex Med
; 20(4): 559-567, 2023 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814112
12.
Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies.
Support Care Cancer
; 31(8): 453, 2023 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428241
13.
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.
Prostate
; 82(7): 876-879, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254666
14.
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Cancer
; 128(2): 269-274, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516660
15.
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
Mod Pathol
; 35(8): 1092-1100, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35145197
16.
Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
J Urol
; 207(4): 832-840, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34854749
17.
The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer.
J Urol
; 207(5): 1001-1009, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34981949
18.
Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
J Urol
; 207(1): 127-136, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433304
19.
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
J Urol
; 208(5): 1037-1045, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830553
20.
Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula.
Eur J Epidemiol
; 37(12): 1205-1213, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289138